Total trials
231
Active
45
Phase 3
3
Total enrollment
60,440
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| MoviPrep | — | — | — | — | — | 2 | |
| Vancomycin | — | — | — | — | — | 1 | |
| Full Spectrum Microbiota | — | — | — | — | — | 1 | |
| vancomycin, Miralax, intestinal microbiota | — | — | — | — | — | 1 |
Next readouts
- 2022-04-15
- 2025-02-28
Top conditions
- Physical Activity14
- Depression11
- Stress11
- Obesity9
- Dehydration8
- Sleep8
- Quality of Life7
- Anxiety6
Frequently asked questions about Arizona State University
- How many clinical trials does Arizona State University have on ClinicalTrials.gov?
- Arizona State University is listed as the lead sponsor on 231 clinical trials in ClinicalTrials.gov, 45 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Arizona State University's trials are in Phase 3?
- 3 of Arizona State University's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Arizona State University focus on?
- Arizona State University's most-studied conditions on ClinicalTrials.gov are Physical Activity, Depression, Stress, Obesity, Dehydration.
- When are Arizona State University's next clinical trial readouts?
- Arizona State University has 2 upcoming primary-completion readouts tracked here; the soonest is “Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders”, expected around 2022-04-15.